usd from 3.8 to 4.1 from may to july, forex up already. Should be good result, and the deferred tax already 2.3 million for last quarter, so this quarter should not be charged so much. fly fly fly hopefully
This is logistic cost to settle the fda issue. No worry-lah. Once settle the fda issue, the the profit is back to 9 mil per quarter. If drop, I will buy more for long-term investment.
In business definetely have some hiccup. As long as the revenue won’t drop, it means the business is still intact. They only need to do some touch up to go back to normal.
the management is not transparent enough in handling FDA issue. I thought august should have result about the FDA issue. But they spent 38 million for PPE, is that good sign?
there won't be impairment on the return goods as it can be sorted out and sell back to those non-us countries. That's why they act fast to get the container to return back to their plant and sell back to non-medical product and improve their cash flow, The management do a good job in handling the fda issue.
1. INTRODUCTION The Board of Directors of CGB (“Board”) wishes to announce that the Company had on 28 September 2018 proposed to acquire 500,000 ordinary shares, representing 100% equity interest in Pacewell Asia Sdn. Bhd. (“Pacewell”) (“Sale Shares”) from the “Related Parties” stated in Item 2 below for a total cash consideration of Ringgit Malaysia One Hundred Fifty Thousand (RM150,000) (“Purchase Price”), resulting in Pacewell becoming a wholly owned subsidiary of CGB. (herein referred to as “the Proposed Acquisition”)
RATIONALE OF THE PROPOSED ACQUISITION
Currently, Pacewell owned a 510(k) licence under Food and Drug Administration (FDA), United States which enable the Company to immediately export a medium-risk medical device in United States without having the hassle to apply for a new license which could take a few months to a year’s time and also the application cost involved. In addition, the Proposed Acquisition will help to mitigate the business risk by possessing additional FDA licence
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Yael Jasper
2,178 posts
Posted by Yael Jasper > 2018-09-21 10:32 | Report Abuse
Strong momentum time to invest now.